- Home
- ESP vs AVTX Comparison
ESP vs AVTX Comparison
Compare ESP & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESP | AVTX |
|---|---|---|
| Founded | 1928 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 171.4M | 339.9M |
| IPO Year | 1995 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ESP | AVTX |
|---|---|---|
| Price | $58.00 | $15.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $32.57 |
| AVG Volume (30 Days) | 18.5K | ★ 568.0K |
| Earning Date | 01-01-0001 | 04-20-2026 |
| Dividend Yield | ★ 1.84% | N/A |
| EPS Growth | 31.88 | ★ 81.66 |
| EPS | ★ 1.75 | N/A |
| Revenue | ★ $43,950,872.00 | $27,813,137.00 |
| Revenue This Year | $10.30 | N/A |
| Revenue Next Year | $10.00 | N/A |
| P/E Ratio | $31.06 | ★ N/A |
| Revenue Growth | 13.46 | ★ 2312.27 |
| 52 Week Low | $24.85 | $3.39 |
| 52 Week High | $62.15 | $20.72 |
Technical Indicators
Market Signals| Indicator | ESP | AVTX |
|---|---|---|
| Relative Strength Index (RSI) | 52.68 | 45.48 |
| Support Level | $42.46 | $15.36 |
| Resistance Level | $61.58 | $16.40 |
| Average True Range (ATR) | 2.70 | 1.31 |
| MACD | -0.44 | -0.10 |
| Stochastic Oscillator | 54.13 | 24.30 |
Price Performance
Historical ComparisonAbout ESP Espey Mfg. & Electronics Corp.
Espey Manufacturing & Electronics Corp is a power electronics design and OEM manufacturing company delivering products for military and severe environment applications. Its products include power supplies, power converters, filters, power transformers, magnetic components, power distribution equipment, UPS systems, and antennas. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power. Espey services include design and development to specification, build to specifications provided by the customer, build to print, design services, design studies, environmental testing services, metal fabrication, painting services, and development of automatic testing equipment.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).